1.
Kuijpers TW, van Leeuwen EM, Barendregt BH, Klarenbeek P, de Kerk DJ aan, Baars PA, Jansen MH, de Vries N, van Lier RA, van der Burg M. A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells. Haematologica [Internet]. 2013Jun.30 [cited 2026Nov.17];98(7):1030-8. Available from: https://haematologica.org/article/view/6711